Antibody-drug conjugates and their uses

MA69280B1Active Publication Date: 2026-08-31MABLINK BIOSCIENCE SAS

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA69280
Authority / Receiving Office: MA · MA
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2023-03-10
Filing Date: 2023-03-10
Publication Date: 2026-08-31
Estimated Expiration: 2043-03-10

Application Information

Patent Timeline

10 Mar 2023

Priority

10 Mar 2023

Application

MA69280

31 Aug 2026

Publication

MA69280B1

IPC: A61K47/68; A61P35/00; C07K16/28; C07K16/32

CPC: A61K47/6849; A61P35/00; A61K47/68037; C07K16/28; C07K16/32; C07K2317/24; C07K2317/52; C07K2317/33

Inventors: VIRICEL Warren

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to antibody-drug conjugates, wherein the antibody specifically binds to folate receptor a, and wherein the drug is preferably chosen among a cytotoxic drug. Such antibody-drug conjugates are useful in particular in treating proliferative diseases including cancers, such as ovarian, breast and non-small cell lung cancers.

Need to check novelty before this filing date? Find Prior Art

Explore free tools for quick IP tasks

Patent Information

Abstract